These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 660763)

  • 21. Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer.
    Boehme WM; Augspurger RR; Wallner SF; Donohue RE
    Cancer; 1978 Apr; 41(4):1433-9. PubMed ID: 639003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
    Fosså SD; Sokolowski J; Theodorsen L
    Br J Urol; 1978 May; 50(3):185-9. PubMed ID: 753458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative evaluation of bone scanning, histological and biological studies of bone marrow in the staging of prostate cancer].
    Aguirre F; Díaz González R; Leiva O; Mayor J; Borobia V
    Actas Urol Esp; 1981; 5(2):99-104. PubMed ID: 7270287
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum and bone marrow radioimmunoassay of acid phosphatase in prostatic cancer.
    Sarosdy MF; Kledzik G; Lamm DL
    Urology; 1982 Jan; 19(1):33-6. PubMed ID: 6173949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid phosphatase levels in bone marrow: value in detecting early bone metastasis from carcinoma of the prostate.
    Chua DT; Veenema RJ; Muggia F; Graff A
    J Urol; 1970 Apr; 103(4):462-6. PubMed ID: 4191242
    [No Abstract]   [Full Text] [Related]  

  • 26. Bone marrow aspiration biopsy and bone scanning in the staging of prostatic cancer.
    Varenhorst E; Alund G; Lindström E; Månson JC
    Br J Urol; 1983 Oct; 55(5):534-7. PubMed ID: 6626900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive random iliac bone biopsy in advanced prostatic cancer.
    Sy FA; Gursel EO; Veenema RJ
    Urology; 1973 Aug; 2(2):125-7. PubMed ID: 4769515
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological and histochemical evaluation of marrow aspirates in patients with prostatic carcinoma.
    Moncure CW; Johnston CL; Smith MJ; Koontz WW
    J Urol; 1972 Oct; 108(4):609-11. PubMed ID: 4631253
    [No Abstract]   [Full Text] [Related]  

  • 29. Counter immunoelectrophoresis for detection of human prostatic acid phosphatase.
    Romas NA; Hsu KC; Tomashefsky P; Tannenbaum M
    Urology; 1978 Jul; 12(1):79-83. PubMed ID: 80054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of bone marrow acid phosphatase in prostatic carcinoma.
    Alsabti EA; Safo M
    Urol Int; 1979; 34(5):350-5. PubMed ID: 494437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF
    Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemical measurement of serum prostatic acid phosphatase (PAP). Clinical evaluation of radioimmunoassay and counter immunoelectrophoresis.
    Gupta MK; Rajaraman S; Gupta SK; Hewitt CB; Deodhar SD
    Am J Clin Pathol; 1981 Oct; 76(4):430-6. PubMed ID: 6170220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acid phosphatase: new developments.
    Romas NA; Rose NR; Tannenbaum M
    Hum Pathol; 1979 Sep; 10(5):501-12. PubMed ID: 393609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of immunodiffusion assay for prostatic acid phosphatase.
    Moncure CW
    Natl Cancer Inst Monogr; 1978 Dec; (49):241-2. PubMed ID: 107456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
    Pontes JE; Choe BK; Rose NR; Ercole C; Pierce JM
    J Urol; 1981 Sep; 126(3):363-5. PubMed ID: 6168779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acid phosphatase in the bone marrow: diagnostic value in prostatic carcinoma].
    Tenaillon M; Billon B; Kelly A; Toppercer A; Elhilali MM
    J Urol (Paris); 1980; 86(2):107-10. PubMed ID: 7452042
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic staging of prostatic carcinoma: three years of experience.
    Drucker JR; Moncure CW; Johnson CL; Smith MJ; Koontz WW
    J Urol; 1978 Jan; 119(1):94-8. PubMed ID: 413938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical comparison of immunological assays for determining prostatic acid phosphatase.
    Romas NA; Shaw LM; Hsu KC; Ng PY; Pitts M; Tomashefsky P; Tannenbaum M
    Ann N Y Acad Sci; 1982; 390():104-9. PubMed ID: 6178342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.